# MSLN-targeted CAR-T Cells in Solid Tumors.

> **NCT05783089** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 87 (estimated)

## Conditions studied

- Mesothelin-positive Advanced Malignant Solid Tumors

## Interventions

- **BIOLOGICAL:** Anti-mesothelin CAR-T cells

## Key facts

- **NCT ID:** NCT05783089
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-04
- **Primary completion:** 2025-04
- **Final completion:** 2027-04
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05783089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05783089, "MSLN-targeted CAR-T Cells in Solid Tumors.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05783089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*